Micro-organism-like nanoparticles for oral antigen delivery

Journal of Drug Delivery Science and Technology

Volumn 18, Issue 1, 2008, Pages 31-39

  Salman, H H ^a   Gomez S ^a   Gamazo, C ^a   Costa Martins, R ^a   Zabaleta, V ^a   Irache, J M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Bioadhesion; Flagellin; Immunoadjuvant; Lipopolysaccharide; Mannosamine; Nanoparticles

Indexed keywords

ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; FLAGELLIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MANNOSAMINE; NANOPARTICLE; OVALBUMIN; POLYANHYDRIDE; RHODAMINE B; RHODAMINE B ISOTHIOCYANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BRUCELLA OVIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; PEYER PATCH; RAT; SALMONELLA ENTERITIDIS; TH1 CELL; TH2 CELL;

EID: 39449130398     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(08)50004-9     Document Type: Article

References (56)

1. Walker S.M., Pajno G.B., Lima M.T., Wilson D.R., Durham S.R. - Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. - J Allergy Clin Immunol, 107, 87-93, 2001.
2. O'Hagan D.T., Singh M. - Microparticles as vaccine adjuvants and delivery systems. - Expert Rev Vaccines, 2, 269-283, 2003.
3. Gomez S., Gamazo C., Roman B.S., Ferrer M., Sanz M.L., Irache J.M. - Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens. - Vaccine, 25, 5263-5271, 2007.
4. Jain S., Sharma R.K., Vyas S.P. - Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in vitro and in vivo characterization. - J Pharm Pharmacol, 58, 303-310, 2006.
5. Murillo M., Goni M.M., Irache J.M., Arangoa M.A., Blasco J.M., Gamazo C. - Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. - J Control Release, 85, 237-246, 2002.
6. Salman H.H., Gamazo C., Campanero M.A., Irache J.M. - Bioadhesive mannosylated nanoparticles for oral drug delivery. - J Nanosci Nanotechnol, 6, 3203-3209, 2006.
7. Yoncheva K., Guembe L., Campanero M.A., Irache J.M. - Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. - Int J Pharm, 334, 156-165, 2007.
8. Galindo-Rodriguez S.A., Allemann E., Fessi H., Doelker E. - Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. - Crit Rev Ther Drug Carrier Syst, 22, 419-464, 2005.
9. Ochoa J., Irache J.M., Tamayo I., Walz A., DelVecchio V.G., Gamazo C. - Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella enteritidis in mice. - Vaccine, 25, 4410-4419, 2007.
10. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., Brayden D. - Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. - Eur. J. Pharm. Sci, 6, 153-163, 1998.
11. Van Der Lubben I.M., Konings F.A., Borchard G., Verhoef J.C., Junginger H.E. - In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. - J. Drug. Target, 9, 39-47, 2001.
12. Coppi G., Iannuccelli V., Sala N., Bondi M. - Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administration. - J. Microencapsul, 21, 829-839, 2004.
13. Ponchel G., Irache J. - Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. - Adv. Drug. Deliv. Rev, 34, 191-219, 1998.
14. Lavelle E.C. -Targeted delivery of drugs to the gastrointestinal tract. - Crit. Rev. Ther. Drug. Carrier. Syst, 18, 341-386, 2001.
15. Carcaboso A.M., Hernandez R.M., Igartua M., Rosas J.E., Patarroyo M.E., Pedraz J.L. - Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. - Vaccine, 22, 1423-1432, 2004.
16. Hori M., Onishi H., Machida Y. - Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. - Int J Pharm, 297, 223-234, 2005.
17. Conway B., Ronald A. - An overview of some mechanisms of bacterial pathogenesis. - Can J Microbiol, 34, 281-286, 1988.
18. Freter R. - Mechanisms of association of bacteria with mucosal surfaces. - Ciba Found Symp, 80, 36-55, 1981.
19. Sansonetti P.J. - Bacterial pathogens, from adherence to invasion: comparative strategies. - Med Microbiol Immunol, 182, 223-232, 1993.
20. Fadl A.A., Venkitanarayanan K.S., Khan M.I. - Identification of Salmonella enteritidis outer membrane proteins expressed during attachment to human intestinal epithelial cells. - J Appl Microbiol, 92, 180-186, 2002.
21. Allen-Vercoe E., Woodward M.J. - The role of flagella, but not fimbriae, in the adherence of Salmonella enterica serotype Enteritidis to chick gut explant. - J Med Microbiol, 48, 771-780, 1999.
22. Darwin K.H., Miller V.L. - Molecular basis of the interaction of Salmonella with the intestinal mucosa. - Clin Microbiol Rev, 12, 405-428, 1999.
23. Humphries A.D., Townsend S.M., Kingsley R.A., Nicholson T.L., Tsolis R.M., Baumler A.J. - Role of fimbriae as antigens and intestinal colonization factors of Salmonella serovars. - FEMS Microbiol Lett, 201, 121-125, 2001.
24. Kaltner H., Stierstorfer B. - Animal lectins as cell adhesion molecules. - Acta Anat (Basel), 161, 162-179, 1998.
25. Lloyd D.H., Viac J., Werling D., Reme C.A., Gatto H. - Role of sugars in surface microbe-host interactions and immune reaction modulation. - Vet Dermatol, 18, 197-204, 2007.
26. Arbos P., Arangoa M.A., Campanero M.A., Irache J.M. - Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. - Int J Pharm, 242, 129-136, 2002.
27. Salman H.H., Gamazo C., Campanero M.A., Irache J.M. - Salmonella-like bioadhesive nanoparticles. - J. Control. Release, 106, 1-13, 2005.
28. Gamazo C., Winter A.J., Moriyon I., Riezu-Boj J.I., Blasco J.M., Diaz R. - Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. - Infect Immun, 57, 1419-1426, 1989.
29. Galanos C., Luderitz O., Westphal O. - A new method for the extraction of R lipopolysaccharides. - Eur J Biochem, 9, 245-249, 1969.
30. Warren L. - The thiobarbituric acid assay of sialic acids. - J Biol Chem, 234, 1971-1975, 1959.
31. Ochoa-Reparaz J., Sesma B., Alvarez M., Jesus Renedo M., Irache J.M., Gamazo C. - Humoral immune response in hens naturally infected with Salmonella enteritidis against outer membrane proteins and other surface structural antigens. - Vet Res, 35, 291-298, 2004.
32. Benson J.R., Hare P.E. - O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin. - Proc Natl Acad Sci USA, 72, 619-622, 1975.
33. Maciel M., Fusaro A.E., Oliveira C.R., Futata E.A., Duarte A.J., Sato M.N. - IgA response in serum and gut secretion in sensitized mice fed with the dust mite Dermatophagoides pteronyssinus extract. - Braz J Med Biol Res, 37, 817-826, 2004.
34. Cox E., Verdonck F., Vanrompay D., Goddeeris B. - Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. - Vet Res, 37, 511-539, 2006.
35. Dzierzbicka K., Kolodziejczyk A.M. - [Adjuvants - essential components of new generation vaccines]. - Postepy Biochem, 52, 204-211, 2006.
36. Kazzaz J., Singh M., Ugozzoli M., Chesko J., Soenawan E., OHagan D T. - Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency. - J Control Release, 110, 566-573, 2006.
37. Diwan M., Elamanchili P., Lane H., Gainer A., Samuel J. - Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. - J Drug Target, 11, 495-507, 2003.
38. Cui Z., Mumper R.J. - The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. - Eur J Pharm Biopharm, 55, 11-18, 2003.
39. Goldstein J., Hoffman T., Frasch C., Lizzio E.F., Beining P.R., Hochstein D., Lee Y.L., Angus R.D., Golding B. - Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. - Infect Immun, 60, 1385-1389, 1992.
40. Jones L.M., Diaz R., Berman D.T. - Endotoxic activity of rough organisms of Brucella species. - Infect Immun, 13, 1638-1641, 1976.
41. Weiss D.S., Takeda K., Akira S., Zychlinsky A., Moreno E. - MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. - Infect Immun, 73, 5137-5143, 2005.
42. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Ben-Efraim S., Gupta C.K. - Adjuvants - a balance between toxicity and adjuvanticity. - Vaccine, 11, 293-306, 1993.
43. Otte J.M., Cario E., Podolsky D.K. - Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. - Gastroenterology, 126, 1054-1070, 2004.
44. Ogushi K., Wada A., Niidome T., Mori N., Oishi K., Nagatake T., Takahashi A., Asakura H., Makino S., Hojo H., Nakahara Y., Ohsaki M., Hatakeyama T., Aoyagi H., Kurazono H., Moss J., Hirayama T. - Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. - J Biol Chem, 276, 30521-30526, 2001.
45. Robertson J.M., McKenzie N.H., Duncan M., Allen-Vercoe E., Woodward M.J., Flint H.J., Grant G. - Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. - J Med Microbiol, 52, 91-99, 2003.
46. Dalle F., Jouault T., Trinel P.A., Esnault J., Mallet J.M., d'Athis P., Poulain D., Bonnin A. - Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro. - Infect Immun, 71, 7061-7068, 2003.
47. Wagner S., Lynch N.J., Walter W., Schwaeble W.J., Loos M. - Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. - J Immunol, 170, 1462-1465, 2003.
48. Salman H.H., Gamazo C., Campanero M.A., Irache J.M. - Salmonella-like bioadhesive nanoparticles. - J Control Release, 106, 1-13, 2005.
49. Cronkhite R.I., Michael J.G. - Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties. - Vaccine, 22, 2106-2115, 2004.
50. McSorley S.J., Ehst B.D., Yu Y., T., G.A. - Bacterial flagellin is an effective adjuvant for CD4 T cells in vivo. - J Immunol., 169, 3914, 2002.
51. Honko A.N., Mizel S.B. - Effects of flagellin on innate and adaptive immunity. - Immunol Res, 33, 83-102, 2005.
52. Umamaheswari R.B., Jain S., Tripathi P.K., Agrawal G.P., Jain N.K. - Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. - Drug Deliv, 9, 223-231, 2002.
53. Hattori Y., Kawakami S., Suzuki S., Yamashita F., Hashida M. - Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. - Biochem Biophys Res Commun, 317, 992-999, 2004.
54. Dalle F., Dumont L., Franco N., Mesmacque D., Caillot D., Bonnin P., Moiroux C., Vagner O., Cuisenier B., Lizard S., Bonnin A. - Genotyping of Candida albicans oral strains from healthy individuals by polymorphic microsatellite locus analysis. - J Clin Microbiol, 41, 2203-2205, 2003.
55. Engering A.J., Cella M., Fluitsma D., Brockhaus M., Hoefsmit E.C., Lanzavecchia A., Pieters J. - The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. - Eur J Immunol, 27, 2417-2425, 1997.
56. Jain S., Singh P., Mishra V., Vyas S.P. - Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B. - Immunol Lett, 101, 41-49, 2005.